Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) Levels During Emergency Management of Rhabdomyolysis: Predicting Renal Failure

NCT01544231 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.

NCT NCT01544231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01544231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Neutrophil Gelatinase Associated Lipocalin (NGAL) Levels During Emergency Management of Rhabdomyolysis: Predicting Renal Failure
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Phase
Observational
Overall status
Completed
Start date
August 31, 2013
Completion date
December 9, 2015
Enrollment
197 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney failure, rhabdomyolysis